[1]
“Preparation of Rosuvastatin Orodispersible Tablets and Comparative Evaluation with Brand and Generic Marketed Tablets”, Journal of Pharmaceutical Negative Results, vol. 13, no. 3, pp. 31–40, Sep. 2022, doi: 10.47750/pnr.2022.13.03.006.